Danaher Corporation (LON:0R2B)
London · Delayed Price · Currency is GBP · Price in USD 224.67
+0.15 (0.07%)
At close: Dec 19, 2025
Danaher Market Cap
Danaher has a market cap or net worth of 118.75 billion as of December 19, 2025. Its market cap has decreased by -11.52% in one year.
Market Cap
118.75B
Enterprise Value
131.19B
Revenue
18.10B
Ranking
n/a
PE Ratio
45.46
Stock Price
224.67
Market Cap Chart
Since December 10, 1969, Danaher's market cap has increased from 207.76M to 118.75B, an increase of 57,055.92%. That is a compound annual growth rate of 11.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 118.75B | -10.33% |
| Dec 31, 2024 | 132.43B | -1.32% |
| Dec 29, 2023 | 134.20B | -16.31% |
| Dec 30, 2022 | 160.36B | -7.64% |
| Dec 31, 2021 | 173.63B | 50.22% |
| Dec 31, 2020 | 115.58B | 38.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.09B |
| GSK plc | 72.73B |
| Haleon | 32.99B |
| Smith & Nephew | 10.46B |
| Convatec Group | 4.73B |
| Hikma Pharmaceuticals | 3.34B |
| HUTCHMED (China) | 1.75B |
| Genus | 1.74B |